tailieunhanh - Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

Pediatric patients with high-risk neuroblastoma (HR NB) often fail to respond to upfront intensive multimodal therapy. Tumor-acquired suppression of apoptosis contributes to therapy resistance. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN